• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病运动功能恶化至死亡的轨迹

The Trajectory of Motor Deterioration to Death in Parkinson's Disease.

作者信息

Poonja Sabrina, Miyasaki Janis, Fu Xilai, Camicioli Richard, Sang Tina, Yuan Yan, Ba Fang

机构信息

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.

School of Public Health, University of Alberta, Edmonton, AB, Canada.

出版信息

Front Neurol. 2021 Aug 18;12:670567. doi: 10.3389/fneur.2021.670567. eCollection 2021.

DOI:10.3389/fneur.2021.670567
PMID:34484095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8416311/
Abstract

Motor progression varies even among those with a single diagnosis such as Parkinson's disease (PD) and little is known about the trajectory of motor signs prior to death. Understanding deterioration patterns may help clinicians counsel patients and proactively plan interdisciplinary care, including palliative care. The objective of this study was to examine and describe Unified Parkinson's Disease Rating Scale motor score (UPDRS-III) trajectories at the end of life in PD. A retrospective chart review was performed for deceased PD patients who attended the Parkinson and Movement Disorders Program at the University of Alberta for at least 5 years between 1999 and 2018. UPDRS-III scores were recorded for all visits. Trajectory patterns were visualized with Loess curves stratified by sex and age at diagnosis. Piecewise linear models were used to individually model the UPDRS-III scores, and the trajectories obtained were clustered based on their features. Among the 202 charts reviewed, 84 meeting inclusion criteria were analyzed. The UPDRS-III increased over time regardless of sex and age. Distinct trajectory variations present in PD (e.g., Consistent Deterioration, Stability-Deterioration, Improvement-Deterioration, Deterioration-Improvement-Deterioration) were identified. Twenty-five percent of the patients were classified as Undetermined/Irregular trajectories. In addition, regardless of trajectory type, many patients experienced a steep increase in UPDRS-III approaching death. Those with disease diagnosis after age 65 years had a shorter survival time, compared to PD patients with a younger age of onset. Our study identified dominant types of motor trajectory in PD that can help clinicians understand their patients' course of illness. This information can help counsel patients regarding the variability in motor deterioration and should alert physicians to recognize a terminal decline. Age of disease onset was correlated with survival time.

摘要

即使在患有单一诊断疾病(如帕金森病(PD))的患者中,运动进展情况也存在差异,而且对于死亡前运动体征的变化轨迹知之甚少。了解病情恶化模式可能有助于临床医生为患者提供咨询,并积极规划跨学科护理,包括姑息治疗。本研究的目的是检查和描述帕金森病患者临终时统一帕金森病评定量表运动评分(UPDRS-III)的变化轨迹。对1999年至2018年间在阿尔伯塔大学帕金森与运动障碍项目就诊至少5年的已故PD患者进行了回顾性病历审查。记录每次就诊时的UPDRS-III评分。通过按诊断时的性别和年龄分层的局部加权回归散点平滑曲线(Loess曲线)来直观显示变化轨迹模式。使用分段线性模型分别对UPDRS-III评分进行建模,并根据其特征对获得的变化轨迹进行聚类。在审查的202份病历中,分析了84份符合纳入标准的病历。无论性别和年龄,UPDRS-III评分均随时间增加。识别出帕金森病中存在的不同变化轨迹类型(如持续恶化、稳定-恶化、改善-恶化、恶化-改善-恶化)。25%的患者被归类为不确定/不规则变化轨迹。此外,无论变化轨迹类型如何,许多患者在临近死亡时UPDRS-III评分急剧上升。与发病年龄较小的帕金森病患者相比,65岁以后确诊疾病的患者生存时间较短。我们的研究确定了帕金森病中主要的运动变化轨迹类型,这有助于临床医生了解患者的病程。这些信息有助于就运动恶化的变异性为患者提供咨询,并应提醒医生认识到终末期病情恶化。疾病发病年龄与生存时间相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/ebd7848cb380/fneur-12-670567-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/ab2415fb0c05/fneur-12-670567-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/00eed81fde24/fneur-12-670567-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/0446f062a5fd/fneur-12-670567-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/ebd7848cb380/fneur-12-670567-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/ab2415fb0c05/fneur-12-670567-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/00eed81fde24/fneur-12-670567-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/0446f062a5fd/fneur-12-670567-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fca/8416311/ebd7848cb380/fneur-12-670567-g0004.jpg

相似文献

1
The Trajectory of Motor Deterioration to Death in Parkinson's Disease.帕金森病运动功能恶化至死亡的轨迹
Front Neurol. 2021 Aug 18;12:670567. doi: 10.3389/fneur.2021.670567. eCollection 2021.
2
Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD study.在多民族、多中心队列中使用轨迹模型对帕金森病病程和结局进行多因素评估——LONG-PD研究的扩展
Front Aging Neurosci. 2023 Sep 26;15:1240971. doi: 10.3389/fnagi.2023.1240971. eCollection 2023.
3
The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).帕金森病患者生活质量的关键决定因素:帕金森病生物标志物项目(PDBP)的结果。
J Parkinsons Dis. 2016 May 31;6(3):523-32. doi: 10.3233/JPD-160851.
4
Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.帕金森病运动症状的自然史和左旋多巴的长期反应。
Brain. 2020 Aug 1;143(8):2490-2501. doi: 10.1093/brain/awaa181.
5
Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.评估帕金森病非运动症状与健康相关生活质量之间的关系:一项回顾性观察队列研究。
Neurol Sci. 2020 Oct;41(10):2867-2873. doi: 10.1007/s10072-020-04406-5. Epub 2020 Apr 23.
6
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.MDS-UPDRS 是否能精确评估早期帕金森病的进展?帕金森病进展标志物倡议队列的研究结果。
J Neurol. 2019 Aug;266(8):1927-1936. doi: 10.1007/s00415-019-09348-3. Epub 2019 May 9.
7
Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature.经颅重复磁刺激初级运动皮层治疗帕金森病运动症状的文献定量评价
Mov Disord. 2015 May;30(6):750-8. doi: 10.1002/mds.26206. Epub 2015 Mar 18.
8
Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.新诊断帕金森病患者运动进展的临床和遗传预测因素的大规模识别:一项纵向队列研究及验证
Lancet Neurol. 2017 Nov;16(11):908-916. doi: 10.1016/S1474-4422(17)30328-9. Epub 2017 Sep 25.
9
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease.一组中国帕金森病患者便秘的临床特征及相关因素
World J Gastrointest Pharmacol Ther. 2021 Jan 5;12(1):21-31. doi: 10.4292/wjgpt.v12.i1.21.
10
Gender differences in Parkinson's disease.帕金森病中的性别差异。
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):819-24. doi: 10.1136/jnnp.2006.103788. Epub 2006 Nov 10.

引用本文的文献

1
A personalised, gait training telerehabilitation programme for people with Parkinson's Disease: A long-term pilot study.一项针对帕金森病患者的个性化步态训练远程康复计划:一项长期试点研究。
Clin Rehabil. 2025 Aug;39(8):1034-1047. doi: 10.1177/02692155251355880. Epub 2025 Jul 14.
2
Paradigm shift in Parkinson's disease: using continuous telemonitoring to improve symptoms control. Results from a 2-years journey.帕金森病的范式转变:利用持续远程监测改善症状控制。两年历程的结果。
Front Neurol. 2024 Jun 6;15:1415970. doi: 10.3389/fneur.2024.1415970. eCollection 2024.
3
Motor dysfunction in Parkinson's patients: depression differences in a latent growth model.

本文引用的文献

1
Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data Elements.帕金森病的临床进展:来自 NINDS 常见数据元素的见解。
J Parkinsons Dis. 2020;10(3):1075-1085. doi: 10.3233/JPD-201932.
2
Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.比较综合门诊姑息治疗与标准治疗对帕金森病及相关疾病患者的效果:一项随机临床试验。
JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992.
3
Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach.
帕金森病患者的运动功能障碍:潜在增长模型中的抑郁差异
Front Aging Neurosci. 2024 Jun 3;16:1393887. doi: 10.3389/fnagi.2024.1393887. eCollection 2024.
4
End of life care of hospitalized patients with Parkinson disease: a retrospective analysis and brief review.帕金森病住院患者的临终关怀:一项回顾性分析及简要综述。
Front Aging Neurosci. 2023 Sep 6;15:1265156. doi: 10.3389/fnagi.2023.1265156. eCollection 2023.
帕金森病中与照料者负担相关的患者及照料者特征:一种姑息治疗方法
Ann Palliat Med. 2020 Feb;9(Suppl 1):S24-S33. doi: 10.21037/apm.2019.10.01. Epub 2019 Nov 14.
4
Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.路易体病临床异质性的病理影响。
Mov Disord. 2020 Jan;35(1):5-19. doi: 10.1002/mds.27867. Epub 2019 Oct 29.
5
Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial.门诊姑息治疗是否能改善帕金森病患者的以患者为中心的结局:一项实用比较有效性试验的原理、设计和实施。
Contemp Clin Trials. 2019 Apr;79:28-36. doi: 10.1016/j.cct.2019.02.005. Epub 2019 Feb 16.
6
Parkinson disease.帕金森病。
Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.
7
Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.散发性帕金森病脑病理学的神经病理学分期:去伪存真。
J Parkinsons Dis. 2017;7(s1):S71-S85. doi: 10.3233/JPD-179001.
8
Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.多焦点重复经颅磁刺激治疗帕金森病运动和情绪症状:一项随机试验。
Neurology. 2016 Nov 1;87(18):1907-1915. doi: 10.1212/WNL.0000000000003279. Epub 2016 Oct 5.
9
Sex Differences in the Clinical Progression of Parkinson's Disease.帕金森病临床进展中的性别差异
J Obstet Gynecol Neonatal Nurs. 2016 Sep-Oct;45(5):749-56. doi: 10.1016/j.jogn.2016.05.002. Epub 2016 Aug 9.
10
Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype.帕金森病:非运动症状与运动表型之间的关系
Can J Neurol Sci. 2016 Mar;43(2):261-7. doi: 10.1017/cjn.2015.328.